•  
  •  
  •  
  •  

2025-12-03 06:00:00

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • TARC Limited secures Occupancy Certificate for TARC Tripundra
  • India Goes Electric with Maruti Suzuki. One India, One EV Charging platform.
  • Sayaji Hotels Ltd enters into Hotel Management Agreement with Ranjangaon Hotel LLP
  • Quality Power Electrical Equipments Ltd receives order worth Rs. 13.90 crores
  • Apeejay Surrendra Park Hotels Ltd enters into lease agreement with Katsons Hotel and Developer Pvt Ltd

Keywords Selected:  INE540L01014

Stock Report

  • GMP Inspection by Ministry of Health, Armenia at Alkem's manufacturing facility located at Sikkim, India
  • Alkem launches probiotic 'DSS', the original De Simone formulation, in India for gut health management
  • Alkem Foundation and IIT Bombay announce strategic collaboration to set up advanced research centre for immunotherapeutics and regenerative medicines
  • Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer
  • Alkem launches Olesoft Trucera, an advanced ceramide-boosting moisturizing lotion for skin barrier repair
  • Alkem Medtech to acquire 100% stake of Bombay Ortho
  • US FDA Inspection at Alkem Laboratories Ltd's Bioequivalence Center located at Taloja
  • Alkem Laboratories launches generic empagliflozin and its combinations in India under the brand name 'Empanorm'
  • Alkem Laboratories enters into a licensing agreement with US-based Sonnet BioTherapeutics
  • Alkem Laboratories denies claims of Pan-D, Clavam 625 batches being not-of-standard quality
  • Closure of US FDA Inspection at Alkem Laboratories Ltd's manufacturing facility located at Baddi, India
  • Alkem Laboratories Ltd receives Form 483 with 10 observations for Baddi facility
  • Closure of US FDA Inspection at Alkem Laboratories Ltd's API manufacturing facility located at Mandva
  • Alkem Laboratories Ltd updates on sale of S&B Pharma LLC's facility
  • Alkem Laboratories Ltd receives 3 observations from USFDA for API manufacturing facility located at Mandva
  • BIOSERGEN, ALKEM collaborate to develop anti-infective for severe fungal infections
  • Alkem Laboratories Ltd recommends final dividend of Rs. 10
  • Closure of US FDA Inspection at Alkem's manufacturing facility located at Indore
  • Alkem Laboratories Ltd declares special dividend of Rs. 25
  • US FDA Inspection at Alkem's manufacturing facility located at Indore
  • US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA
  • MHRA Inspection at Alkem's Bioequivalence Center at Taloja
  • Alkem Laboratories Ltd board recommends final dividend of Rs. 4
  • US FDA Inspection at Alkem's Bioequivalence Center at Taloja

Latest Post

  • TARC Limited secures Occupancy Certificate for TARC Tripundra
  • India Goes Electric with Maruti Suzuki. One India, One EV Charging platform.
  • Sayaji Hotels Ltd enters into Hotel Management Agreement with Ranjangaon Hotel LLP
  • Quality Power Electrical Equipments Ltd receives order worth Rs. 13.90 crores
  • Apeejay Surrendra Park Hotels Ltd enters into lease agreement with Katsons Hotel and Developer Pvt Ltd


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024